Beyond Algorithms: Preserving ethical and human centric decision making in AI-Driven Drug Development
CDER and CBER have partnered with the European Medicines Agency (EMA) to establish 10 guiding principles aimed at assisting industry and product developers in utilizing artificial intelligence (AI) to enhance drug and biological product development. Most of the other nine principles formalize practices that pharmaceuticals and Biologics industry already understands well such as validation, traceability, […]